CTRI/2025/12/099604尚未招募不适用
A Comparative study of efficacy, safety and tolerance of Olmesartan medoxomil and Azilsartan medoxomil in newly diagnosed patients with stage 1 Hypertension -A prospective observational open label study.
Self1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年4月1日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
研究概览
简要总结
This study is randomized,open label,parralel group ,prospective study comparing the safety efficacyand tolerance of Olmesartan medoxomil 20 mg OD and Azilsartan medoxomil 40 mg OD for 3 months in 100 patients in a tertiary care centre in salem,Taminadu,India.Primary end point is reduction in both systolic and diastolic BP <140/90mmHg at the end of 1st ,2nd and 3rd month.Secondary end point is to record adverse effects of Olmesartan and Azilsartan such as dizziness, fatigue, headache, hyperglycemia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients of both sexes aged more than 18 years with stage 1 hypertension (140-159 systolic BP/90-99 diastolic BP).
- •Patients with associated co-morbid conditions as diabetes, hypothyroidism without complications.
- •Patients who are willing to give consent for the study.
排除标准
- •Patients with stage ll and lll hypertension.
- •Patients already on anti-hypertensive medications.
- •Patients with hypertensive urgencies and emergencies.
- •Along with additional comorbid diseases like coronary artery disease CCF, CKD, stroke and heart, kidney, liver complications.
- •Pregnant and lactating women.
研究者
Dr Kaviya M
Vinayaka Missions Research Foundation
研究点 (1)
Loading locations...
相似试验
招募中
不适用
An observational study on the safety and efficacy of oral administration of 5-deazaflavin TND1128 in subjects with symptoms of agingAge-related symptoms (e.g., fatigue, decreased concentration, sleep disturbance)jRCT103026001910
尚未招募
4 期
Test and compare how effective and safe it is to use Metformin alone versus using both Metformin and Fluoxetine randomly in treating people who have Type 2 Diabetes and have mild depressionCTRI/2024/03/064215Not Available60
尚未招募
4 期
Comparison of Vildagliptin plus Metformin versus Vildagliptin plus Metformin plus Zinc in controlling blood sugar levels among type 2 diabetes mellitus patients.CTRI/2024/10/074542ANJALY MARY VARGHESE410
尚未招募
4 期
Comparison of Rosuvastatin with Rosuvastatin plus zinc in improving serum lipid levels among dyslipidemia patients.CTRI/2024/10/074541Mahima Singh410
招募中
不适用
Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)NCT07413835The Affiliated Hospital of Xuzhou Medical University6